ClearPoint Neuro (CLPT) Change in Accured Expenses (2018 - 2026)
ClearPoint Neuro's Change in Accured Expenses history spans 13 years, with the latest figure at -$6.3 million for Q4 2025.
- On a quarterly basis, Change in Accured Expenses fell 461.95% to -$6.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.5 million, a 342.19% decrease, with the full-year FY2025 number at -$7.5 million, down 342.19% from a year prior.
- Change in Accured Expenses hit -$6.3 million in Q4 2025 for ClearPoint Neuro, down from $693000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for CLPT hit a ceiling of $1.7 million in Q4 2024 and a floor of -$6.3 million in Q4 2025.
- Historically, Change in Accured Expenses has averaged -$109400.0 across 5 years, with a median of $355000.0 in 2022.
- The widest YoY moves for Change in Accured Expenses: up 443.4% in 2022, down 1181.48% in 2022.
- Tracing CLPT's Change in Accured Expenses over 5 years: stood at -$133000.0 in 2021, then surged by 352.63% to $336000.0 in 2022, then rose by 11.31% to $374000.0 in 2023, then skyrocketed by 363.1% to $1.7 million in 2024, then tumbled by 461.95% to -$6.3 million in 2025.
- Business Quant data shows Change in Accured Expenses for CLPT at -$6.3 million in Q4 2025, $693000.0 in Q3 2025, and $938000.0 in Q2 2025.